查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018652

醫療影像外包市場：依服務、模式、合約模式、最終用戶和部署模式分類－2026-2032年全球市場預測

Medical Imaging Outsourcing Market by Service, Modality, Engagement Model, End User, Deployment Model - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療影像外包市場價值將達到 80.7 億美元，到 2026 年將成長至 85.6 億美元，到 2032 年將達到 122.1 億美元，複合年成長率為 6.09%。

主要市場統計數據
基準年 2025 80.7億美元
預計年份：2026年 85.6億美元
預測年份 2032 122.1億美元
複合年成長率 (%) 6.09%

從策略觀點解釋為什麼醫療影像外包已成為醫療保健系統臨床效率、品質和營運韌性的重要能力。

醫療影像外包已從單純的臨時支援發展成為提升臨床處理能力、診斷品質和營運韌性的策略手段。醫療機構既要努力提高影像的速度和準確性，又要控制成本並整合先進的分析能力，兩者之間需要權衡。在此背景下，領導者需要重新思考與供應商的關係、技術整合路徑和人才模式，以創造永續的價值。

技術進步、勞動力動態變化以及不斷變化的採購期望如何從根本上重塑外包醫療影像領域的合作夥伴選擇和交付模式。

醫療影像外包格局正經歷一場變革，其驅動力包括技術成熟、人才動態以及支付方和監管機構不斷變化的期望。基於人工智慧的影像分析技術的進步，使得工作流程分診、量化和初步解讀的自動化程度更高，進而改變了外包給外部合作夥伴的工作範圍。因此，醫療服務提供者越來越傾向於尋找能夠提供整合平台（整合歸檔管理、報告和分析功能）的供應商，而非僅僅提供單一的解決方案服務。

2025年美國費率變化預測及其對醫療影像外包服務的採購、資料居住和成本結構的策略影響

2025年美國政策介入和關稅調整將為依賴跨境服務、硬體進口和國際軟體授權的機構帶來新的營運考量。影響醫療設備組件、影像硬體和資料中心設備的關稅變化可能會改變總成本計算，並促使籌資策略進行短期調整。醫療服務提供者和供應商在合約談判和資本規劃中必須考慮潛在的關稅轉嫁、更長的採購週期以及替代採購途徑。

整合服務類型、模式複雜性、合約模式、最終使用者需求和部署選項的實用細分見解，以最佳化外包決策。

一套精細的細分框架清楚地分類了外包生態系統中價值創造與風險集中並存的各個領域。根據服務細分，外包服務包括歸檔、諮詢、影像分析、報告撰寫和遠距放射診斷，其中影像分析中基於人工智慧的分析與傳統的電腦輔助檢測工具之間存在明確的界限。遠距放射診斷合約涵蓋了從日常和非工作時間的初步解讀專業會診的二次解讀。這種層級式的服務分類系統使買方能夠確定應優先考慮的是強大的分析平台、解讀能力或歸檔管理能力。

影響外包策略和供應商選擇的美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和營運考量。

區域趨勢對醫療外包策略的發展和實施有顯著影響。在美洲，買家往往優先考慮嚴格的監管合規性、與電子健康記錄的深度整合，以及在都市區三級醫療機構中的資料安全和快速反應能力。這些期望要求供應商建立本地處理能力，並在合約中就事件回應和可審計性做出保證。

診斷影像外包的關鍵競爭優勢包括整合人工智慧能力、臨床品質框架、靈活的合約模式和強大的本地執行能力。

外包診斷影像市場的競爭優勢源自於臨床專業知識、技術整合和可擴展的交付模式的結合。領先的供應商透過提供檢驗的AI輔助工具來脫穎而出，這些工具可與PACS和EHR環境無縫整合，同時還擁有強大的品管體系，並促進醫生在複雜病例上的密切合作。那些投資專家組並維持嚴格的同儕審查流程的供應商，往往能夠與尋求在保證品質的同時擴大服務能力的醫院和診斷中心建立長期夥伴關係。

透過幫助醫療保健領導者選擇供應商、制定合約、檢驗人工智慧並分階段實施，我們提供可操作且優先的步驟，以確保臨床品質和連續性。

領導者應優先採取一系列切實可行的措施，以確保外包合約能夠同時確保臨床品質和營運韌性。首先，應將互通性和人工智慧檢驗標準納入供應商選擇流程，使任何合作夥伴都能證明其與現有影像系統無縫連接，並提供相關臨床人群演算法效能的實證數據。這有助於降低後續整合風險，並有助於獲得可重複的診斷結果。

我們高度透明、多方面的調查方法，結合了與關鍵相關人員的訪談、技術檢驗和嚴格的二次調查，從而支持可操作的見解。

本調查方法融合了深度訪談、技術檢驗和結構化二手分析，旨在建立一個可靠、整體情況的市場動態和最佳營運實務視角。深度研究包括對臨床負責人、放射科主任、採購負責人和供應商高階主管進行深度訪談，以獲取關於服務績效、挑戰和策略重點的第一手觀點。這些定性資訊與人工智慧檢驗研究、供應商整合案例研究以及監管指南的技術審查相結合，以驗證研究結果並評估其普適性。

簡要概述重點介紹了供應商能力、人工智慧整合和管治的策略一致性，這是有效醫療影像外包計畫的基礎。

醫學影像外包的演進反映了臨床服務向模組化、技術驅動型轉變的趨勢，這種轉變優先考慮可靠性、擴充性和互通性。那些採取策略性外包方法，將供應商能力與設備需求、合約偏好和當地監管實際情況相匹配的機構，更有利於提升診斷處理能力並維持臨床品質。關鍵主題包括人工智慧在輔助放射科醫生方面發揮越來越重要的作用、靈活的合約模式對於控制成本和風險的重要性，以及建立健全的資料管治以維護相關人員之間信任的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療影像外包市場：依服務類型分類

  • 檔案
  • 諮詢
  • 影像分析
    • 基於人工智慧的分析
    • CAD
  • 建立報告
  • 遠端放射診斷
    • 初步圖像判讀
    • 二次影像解讀

第9章：醫療影像外包市場：依影像模式分類

  • 電腦斷層掃描
  • MRI
  • 核子醫學掃描術診斷
    • PET
    • SPECT
  • 超音波
  • X光

第10章：依合約模式分類的醫療影像外包市場

  • 企劃為基礎
  • 基於訂閱
  • 交易類型

第11章 醫療影像外包市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 診斷中心
  • 醫院

第12章 醫療影像外包市場：依部署模式分類

  • 近岸
  • 離岸
  • 陸上

第13章 醫療影像外包市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫療影像外包市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 醫療影像外包市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫療影像外包市場

第17章：中國醫療影像外包市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa-Gevaert Group NV
  • Alliance Medical Limited
  • Argus Radiology, Inc.
  • Canon Medical Systems Corporation
  • Diagnostic Imaging Services, Inc.
  • Envision Healthcare Corporation
  • Flatworld Solutions Pvt. Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi High-Tech Corporation
  • Imbio, LLC
  • Kayi Healthcare Ltd.
  • Koninklijke Philips NV
  • Medica Reporting Ltd.
  • MetaMed, Inc.
  • North American Science Associates, LLC
  • Nuance Communications, Inc.
  • ONRAD, Inc.
  • ProScan Imaging, LLC
  • RadNet, Inc.
  • Shields MRI, Inc.
  • Siemens Healthineers AG
  • Teleradiology Solutions, Inc.
  • Toshiba Corporation
  • Virtual Radiologic Corporation
Product Code: MRR-2214614770FD

The Medical Imaging Outsourcing Market was valued at USD 8.07 billion in 2025 and is projected to grow to USD 8.56 billion in 2026, with a CAGR of 6.09%, reaching USD 12.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.07 billion
Estimated Year [2026] USD 8.56 billion
Forecast Year [2032] USD 12.21 billion
CAGR (%) 6.09%

A strategic orientation explaining why outsourcing medical imaging is now a critical capability for clinical efficiency, quality, and operational resilience in health systems

Outsourcing of medical imaging functions has moved from occasional support to a strategic lever that shapes clinical throughput, diagnostic quality, and operational resilience. Healthcare organizations are balancing pressure to improve timeliness and accuracy of imaging interpretations with the need to control costs and to integrate advanced analytics. This environment requires leaders to rethink vendor relationships, technology integration pathways, and workforce models in order to capture sustainable value.

The purpose of this executive summary is to synthesize the structural forces reshaping the outsourcing landscape, highlight practical segmentation and regional considerations, and present actionable recommendations that support confident decision-making. It draws on recent trends in artificial intelligence adoption, cross-border delivery models, regulatory developments, and supply-chain dynamics to present a coherent narrative for executives. By focusing on how service types, modalities, engagement and deployment models, and end-user settings interact, the analysis clarifies where incremental investments and strategic pivots can yield measurable improvements in patient care and operational efficiency.

Ultimately, the introduction positions outsourcing not merely as a transaction but as an integrated capability that, when designed intentionally, augments clinical capacity, reduces turnaround variability, and creates pathways for continuous quality improvement. Subsequent sections unpack the transformative shifts, regulatory headwinds, segmentation insights, regional dynamics, and practical next steps leaders should prioritize.

How technological advances, shifting workforce dynamics, and evolving procurement expectations are fundamentally reshaping partner selection and delivery models in outsourced imaging

The landscape of medical imaging outsourcing is undergoing transformative shifts driven by technological maturation, workforce dynamics, and evolving payer and regulatory expectations. Advances in AI-based image analysis are enabling higher levels of automation across workflow triage, quantification, and preliminary reads, which in turn is altering the tasks outsourced to external partners. As a result, providers are increasingly seeking supply partners that can deliver integrated platforms combining archive management, report generation, and analytics rather than discrete, point-solution services.

Concurrently, workforce shortages and the uneven geographic distribution of radiology expertise have intensified demand for flexible reading models. Primary and secondary reading arrangements are being rethought to optimize specialty coverage and to reduce latency for emergent and after-hours studies. This is complemented by a rise in subscription and project-based engagement models that allow health systems to scale capacity predictably and to align vendor incentives with clinical quality measures.

Integration and interoperability expectations have shifted as well. Buyers now prioritize vendors capable of seamless connectivity with enterprise PACS, EHRs, and clinical decision support systems, preserving data provenance and enabling downstream AI tool validation. Finally, the rise of nearshore, offshore, and onshore deployment options has expanded the palette of delivery choices, prompting institutions to define trade-offs between cost, data residency, and clinical governance. Together, these forces are reshaping procurement criteria and the competitive dynamics among service providers.

Projected 2025 tariff adjustments in the United States and their strategic implications for procurement, data residency, and the cost structure of outsourced imaging services

Policy interventions and tariff adjustments in the United States in 2025 are creating new operational considerations for organizations that rely on cross-border services, hardware imports, and international software licensing. Tariff changes that affect medical device components, imaging hardware, and data-center related equipment alter total cost calculus and may prompt near-term shifts in procurement strategies. Providers and vendors must now factor potential tariff pass-through, longer procurement cycles, and alternative sourcing pathways into contractual negotiations and capital planning.

Beyond hardware, tariffs can influence where vendors locate processing infrastructure and how they structure deployment models such as onshore, nearshore, or offshore options. Some vendors may respond by increasing onshore processing capabilities to minimize exposure to cross-border tariffs and to address client concerns about data residency and regulatory compliance. These shifts can increase per-unit costs but may also reduce risk and support higher assurance of service continuity, which is often valued by hospitals and diagnostic centers.

Importantly, tariff-driven adjustments are amplifying the importance of flexible engagement models and modular service design. Subscription and transaction-based arrangements that clearly delineate responsibilities for hardware refresh, software maintenance, and import-related costs help manage budgetary volatility. As a result, executive teams should integrate tariff exposure assessments into vendor selection frameworks and revisit contractual terms related to cost escalation, pass-through clauses, and contingency planning.

Actionable segmentation insights that reconcile service types, modality complexities, engagement models, end-user demands, and deployment choices to optimize outsourcing decisions

A nuanced segmentation framework clarifies where value creation and risk concentration coexist within the outsourcing ecosystem. Based on service breakdowns, outsourcing covers archiving, consulting, image analysis, reporting, and teleradiology, and within image analysis there is a clear delineation between AI-based analysis and traditional computer-aided detection tools. Teleradiology engagements span primary reading for routine and after-hours coverage as well as secondary reading for subspecialty consultation. This layered service taxonomy helps buyers identify whether to prioritize vendors with strong analytics platforms, reading capacity, or archive management capabilities.

In modality terms, CT scan, MRI, nuclear imaging, ultrasound, and x-ray present distinct clinical and operational requirements; nuclear imaging itself differentiates into PET and SPECT workflows which carry unique tracer logistics, regulatory parameters, and interpretive complexity. These modality distinctions influence turnaround expectations, reporting templates, and training requirements for external reading teams. Engagement models further shape financial and operational relationships, with project-based contracts suited to time-bound initiatives, subscription-based models providing predictable access to capacity and capabilities, and transaction-based arrangements offering pay-per-use flexibility.

End-user context is equally decisive: ambulatory surgical centers, clinics, diagnostic centers, and hospitals each impose different throughput, accreditation, and integration demands. Deployment model choices between nearshore, offshore, and onshore delivery affect considerations around data sovereignty, latency, and clinical governance. Together, these segmentation lenses enable leaders to map vendor offerings to clinical workflows and to design contracts that align incentives, mitigate compliance exposures, and preserve continuity of patient care.

Comparative regional dynamics and operational considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape outsourcing strategies and vendor selection

Regional dynamics materially influence how outsourcing strategies are constructed and executed. In the Americas, buyer emphasis tends toward robust regulatory compliance, strong integration with electronic health records, and a premium on data security and rapid turnaround for urban tertiary centers. These expectations push vendors to establish localized processing and to offer contractual assurances around incident response and auditability.

In Europe, Middle East & Africa, heterogeneity across regulatory regimes, reimbursement systems, and digital maturity creates both challenges and opportunities. Providers operating in these regions must navigate cross-border data transfer rules, localization preferences, and diverse clinical pathways, which often makes a hybrid approach combining onshore and nearshore resources the most practical. Vendor partnerships that demonstrate adaptability to regional regulatory nuances and multilingual reporting capabilities gain traction.

Asia-Pacific markets place a premium on scalability, rapid adoption of AI-enabled workflows, and cost-efficient delivery models that can support high-volume diagnostic centers. Vendor strategies in this region frequently emphasize partnerships with local clinical leaders, scalable subscription models, and flexible deployment architectures to meet the wide range of facility types from large hospitals to community clinics. Across all regions, successful outsourcing models reflect a balance between compliance, clinical quality, and operational economics.

Key competitive differentiators in outsourced imaging including integrated AI capabilities, clinical quality frameworks, flexible engagement models, and strong regional execution

Competitive positioning in the outsourced imaging market is anchored in a combination of clinical expertise, technology integration, and scalable delivery operations. Leading vendors differentiate by offering validated AI-assisted tools that integrate smoothly into PACS and EHR environments, by maintaining robust quality management systems, and by demonstrating strong clinician-to-clinician engagement practices for complex cases. Providers that invest in specialty panels and maintain rigorous peer-review workflows tend to secure long-term partnerships with hospitals and diagnostic centers looking to safeguard quality while expanding capacity.

Operational excellence also hinges on flexible engagement and deployment choices. Vendors that can present transparent service-level agreements, clear escalation pathways, and measurable quality metrics for turn-around times and interpretive concordance gain higher trust from institutional buyers. Moreover, companies that invest in data governance, encryption, and compliance certifications address enterprise procurement risk requirements and differentiate on the basis of security assurances.

Finally, strategic collaborations between technology vendors, clinical networks, and local service providers are increasingly common. Such alliances allow companies to combine proprietary AI capabilities with deep clinical domain expertise and regional presence, enabling them to serve complex enterprise accounts with integrated solutions that span archive management, analysis, reporting, and teleradiology services.

Practical and prioritized actions for healthcare leaders to select vendors, structure contracts, validate AI, and phase implementations to safeguard clinical quality and continuity

Leaders should prioritize a set of pragmatic actions to ensure outsourcing arrangements deliver both clinical quality and operational resilience. First, incorporate interoperability and AI validation criteria into the vendor selection process so that any partner can demonstrate seamless connectivity with existing imaging systems and provide empirical evidence of algorithmic performance across relevant clinical populations. This reduces downstream integration risk and supports reproducible diagnostic outputs.

Second, structure contracts to allocate tariff and supply-chain risks transparently, including clauses for cost escalation, hardware replacement responsibilities, and contingency plans for geopolitical disruptions. Aligning commercial terms with clear service-level metrics and governance forums ensures accountability and facilitates continuous improvement. Third, adopt a phased deployment approach for new outsourcing relationships that begins with well-defined pilot programs focused on high-impact modalities or clinical pathways, enabling iterative learning and minimizing operational disruption.

Fourth, invest in clinician engagement and change management to support adoption of AI-augmented workflows and remote reading protocols. Regular case reviews, joint quality audits, and shared KPIs between buyers and vendors foster trust and drive performance. Finally, for organizations with stringent data residency requirements, consider hybrid delivery models that combine onshore processing for sensitive workloads with nearshore or offshore capacity for volume fluctuations, thereby balancing cost, compliance, and scalability.

A transparent, multi-source methodological approach combining primary stakeholder interviews, technical validation, and rigorous secondary research to underpin actionable insights

The research methodology integrates primary interviews, technical validation, and structured secondary analysis to create a reliable picture of market dynamics and operational best practices. Primary research comprised in-depth interviews with clinical leaders, radiology department heads, procurement officers, and vendor executives to capture firsthand perspectives on service performance, pain points, and strategic priorities. These qualitative inputs were synthesized with technical reviews of AI validation studies, vendor integration case studies, and regulatory guidance to triangulate findings and assess generalizability.

Secondary analysis drew on public regulatory documents, peer-reviewed clinical literature, vendor technical white papers, and standards from professional radiology societies to provide context and to validate trends observed in primary engagements. Where proprietary or sensitive contractual terms were discussed in interviews, anonymized case summaries were used to preserve confidentiality while enabling pattern recognition across engagements. Data quality checks included cross-validation of reported performance metrics against clinical validation studies and consistency checks across multiple interviewees working within similar clinical settings.

The resulting methodology emphasizes transparency and reproducibility: assumptions and data sources are documented, methodological limitations are acknowledged, and scenarios are framed to support decision-makers rather than to predict specific quantitative outcomes. This approach ensures that insights are actionable and grounded in both technical evidence and operational realities.

A concise synthesis emphasizing strategic alignment of vendor capabilities, AI integration, and governance as the foundations of effective outsourced imaging programs

The evolution of medical imaging outsourcing reflects a broader shift toward modularized, technology-enabled clinical services that prioritize reliability, scalability, and interoperability. Organizations that approach outsourcing strategically-by aligning vendor capabilities with modality needs, engagement preferences, and regional regulatory realities-are better positioned to realize improvements in diagnostic throughput and to protect clinical quality. Key themes include the growing role of AI in augmenting human readers, the importance of flexible contractual models to manage cost and risk, and the need for robust data governance to maintain trust across stakeholders.

Decision-makers should view outsourcing as a configurable capability that can reduce variability in service delivery while supporting strategic objectives such as specialist access, after-hours coverage, and analytic enablement. Success depends on careful vendor selection, pilot-led deployments, and ongoing clinician engagement that reinforces shared accountability for patient outcomes. Ultimately, a thoughtful outsourcing strategy can be a differentiator in delivering timely, accurate diagnostics and in enabling institutions to scale clinical services without compromising governance or safety.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Imaging Outsourcing Market, by Service

  • 8.1. Archiving
  • 8.2. Consulting
  • 8.3. Image Analysis
    • 8.3.1. Ai-Based Analysis
    • 8.3.2. Cad
  • 8.4. Reporting
  • 8.5. Teleradiology
    • 8.5.1. Primary Reading
    • 8.5.2. Secondary Reading

9. Medical Imaging Outsourcing Market, by Modality

  • 9.1. CT Scan
  • 9.2. MRI
  • 9.3. Nuclear Imaging
    • 9.3.1. Pet
    • 9.3.2. Spect
  • 9.4. Ultrasound
  • 9.5. X-Ray

10. Medical Imaging Outsourcing Market, by Engagement Model

  • 10.1. Project-Based
  • 10.2. Subscription-Based
  • 10.3. Transaction-Based

11. Medical Imaging Outsourcing Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals

12. Medical Imaging Outsourcing Market, by Deployment Model

  • 12.1. Nearshore
  • 12.2. Offshore
  • 12.3. Onshore

13. Medical Imaging Outsourcing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Imaging Outsourcing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Imaging Outsourcing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Imaging Outsourcing Market

17. China Medical Imaging Outsourcing Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agfa-Gevaert Group N.V.
  • 18.6. Alliance Medical Limited
  • 18.7. Argus Radiology, Inc.
  • 18.8. Canon Medical Systems Corporation
  • 18.9. Diagnostic Imaging Services, Inc.
  • 18.10. Envision Healthcare Corporation
  • 18.11. Flatworld Solutions Pvt. Ltd.
  • 18.12. Fujifilm Holdings Corporation
  • 18.13. GE HealthCare Technologies Inc.
  • 18.14. Hitachi High-Tech Corporation
  • 18.15. Imbio, LLC
  • 18.16. Kayi Healthcare Ltd.
  • 18.17. Koninklijke Philips N.V.
  • 18.18. Medica Reporting Ltd.
  • 18.19. MetaMed, Inc.
  • 18.20. North American Science Associates, LLC
  • 18.21. Nuance Communications, Inc.
  • 18.22. ONRAD, Inc.
  • 18.23. ProScan Imaging, LLC
  • 18.24. RadNet, Inc.
  • 18.25. Shields MRI, Inc.
  • 18.26. Siemens Healthineers AG
  • 18.27. Teleradiology Solutions, Inc.
  • 18.28. Toshiba Corporation
  • 18.29. Virtual Radiologic Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ARCHIVING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ARCHIVING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ARCHIVING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY AI-BASED ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY AI-BASED ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY AI-BASED ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY REPORTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY REPORTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY REPORTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY PRIMARY READING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY PRIMARY READING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY PRIMARY READING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SECONDARY READING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SECONDARY READING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SECONDARY READING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CT SCAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CT SCAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CT SCAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY PROJECT-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY PROJECT-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY PROJECT-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SUBSCRIPTION-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SUBSCRIPTION-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SUBSCRIPTION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TRANSACTION-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TRANSACTION-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TRANSACTION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NEARSHORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NEARSHORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NEARSHORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY OFFSHORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY OFFSHORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY OFFSHORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ONSHORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ONSHORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ONSHORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 171. GCC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 174. GCC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 177. GCC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 198. G7 MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 201. G7 MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 204. G7 MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. G7 MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 207. NATO MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 210. NATO MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 212. NATO MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 213. NATO MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 214. NATO MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY IMAGE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY TELERADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA MEDICAL IMAGING OUTSOURCING MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)